Cargando…
1602P COVID-19 vaccination efficacy in cancer patients: An ongoing prospective trial
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454315/ http://dx.doi.org/10.1016/j.annonc.2021.08.1595 |
| _version_ | 1784570460352020480 |
|---|---|
| author | Da Cruz Tomas, T.F. Eiriz, I.F. Vitorino, M. Vicente, R.S. Mendes, A.D. Sousa, M.C. Silva Braga, S. Fiuza, T.M. Gonçalves, L.A. Gonçalves, C.P. Demengeot, J. |
| author_facet | Da Cruz Tomas, T.F. Eiriz, I.F. Vitorino, M. Vicente, R.S. Mendes, A.D. Sousa, M.C. Silva Braga, S. Fiuza, T.M. Gonçalves, L.A. Gonçalves, C.P. Demengeot, J. |
| author_sort | Da Cruz Tomas, T.F. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8454315 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84543152021-09-21 1602P COVID-19 vaccination efficacy in cancer patients: An ongoing prospective trial Da Cruz Tomas, T.F. Eiriz, I.F. Vitorino, M. Vicente, R.S. Mendes, A.D. Sousa, M.C. Silva Braga, S. Fiuza, T.M. Gonçalves, L.A. Gonçalves, C.P. Demengeot, J. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2021-09 2021-09-21 /pmc/articles/PMC8454315/ http://dx.doi.org/10.1016/j.annonc.2021.08.1595 Text en Copyright © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Da Cruz Tomas, T.F. Eiriz, I.F. Vitorino, M. Vicente, R.S. Mendes, A.D. Sousa, M.C. Silva Braga, S. Fiuza, T.M. Gonçalves, L.A. Gonçalves, C.P. Demengeot, J. 1602P COVID-19 vaccination efficacy in cancer patients: An ongoing prospective trial |
| title | 1602P COVID-19 vaccination efficacy in cancer patients: An ongoing prospective trial |
| title_full | 1602P COVID-19 vaccination efficacy in cancer patients: An ongoing prospective trial |
| title_fullStr | 1602P COVID-19 vaccination efficacy in cancer patients: An ongoing prospective trial |
| title_full_unstemmed | 1602P COVID-19 vaccination efficacy in cancer patients: An ongoing prospective trial |
| title_short | 1602P COVID-19 vaccination efficacy in cancer patients: An ongoing prospective trial |
| title_sort | 1602p covid-19 vaccination efficacy in cancer patients: an ongoing prospective trial |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454315/ http://dx.doi.org/10.1016/j.annonc.2021.08.1595 |
| work_keys_str_mv | AT dacruztomastf 1602pcovid19vaccinationefficacyincancerpatientsanongoingprospectivetrial AT eirizif 1602pcovid19vaccinationefficacyincancerpatientsanongoingprospectivetrial AT vitorinom 1602pcovid19vaccinationefficacyincancerpatientsanongoingprospectivetrial AT vicenters 1602pcovid19vaccinationefficacyincancerpatientsanongoingprospectivetrial AT mendesad 1602pcovid19vaccinationefficacyincancerpatientsanongoingprospectivetrial AT sousamcsilva 1602pcovid19vaccinationefficacyincancerpatientsanongoingprospectivetrial AT bragas 1602pcovid19vaccinationefficacyincancerpatientsanongoingprospectivetrial AT fiuzatm 1602pcovid19vaccinationefficacyincancerpatientsanongoingprospectivetrial AT goncalvesla 1602pcovid19vaccinationefficacyincancerpatientsanongoingprospectivetrial AT goncalvescp 1602pcovid19vaccinationefficacyincancerpatientsanongoingprospectivetrial AT demengeotj 1602pcovid19vaccinationefficacyincancerpatientsanongoingprospectivetrial |